Lantern Pharma Inc. Common Stock

LTRNNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
2.18 USD
↗ 0.07 (3.32%)AT CLOSE (11:59 AM EDT)
2.20
↗ 0.01 (0.69%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
2.20
↗ 0.01 (0.69%)
🟢Market: OPEN

Lantern Pharma Inc. Common Stock (LTRN) is currently trading at $2.20. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (579.8%) and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Aug 25, 2026.

Open?$2.11
High?$2.34
Low?$2.10
Prev. Close?$2.11
Volume?124.0K
Avg. Volume?102.1K
VWAP?$2.21
Rel. Volume?1.21x
Bid / Ask
Bid?$1.78 × 100
Ask?$2.71 × 100
Spread?$0.93
Midpoint?$2.25
Valuation & Ratios
Market Cap?27.0M
Shares Out?12.8M
Float?7.3M
Float %?64.2%
P/E Ratio?N/A
P/B Ratio?-8.38
EPS?-$1.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyAI & Machine Learning›AI-Powered Analytics & Decision Systems
Employees
16
Market Cap
27.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.lanternpharma.com
Listed
2020-06-11
Address
1920 MCKINNEY AVENUE
DALLAS, TX 75201
Phone: 972-277-1136
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
44
Piotroski F-Score?0/9Weak
Altman Z-Score?-20.84Distress
Confidence?44%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.56%Elevated
Short Interest?693.0K
Days to Cover?8.1
Free Float7.3M
Avg Daily Volume85.8K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.96Adequate
Quick Ratio?1.96Adequate
Cash Ratio?1.54Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-8.38CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
579.8%STRONG▾
ROA?
S&P
3
-216.8%WEAK▾
Cash Flow & Enterprise
FCF?$-14078189
Enterprise Value?$20.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist